Found 37 results
Filters: Author is Rusinek, Henry  [Clear All Filters]
2024
Mehta NH, Wang X, Keil SA, Xi K, Zhou L, Lee K, Tan W, Spector E, Goldan A, Kelly J et al..  2024.  [1-11C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjects.. Fluids Barriers CNS. 21(1):30.
Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He T, Gutierrez-Jimenez E, Fillmore NR, Bubu OM et al..  2024.  The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.. Res Sq.
2022
Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, P Mozley D, Nehmeh S, Pahlajani S, Wang X et al..  2022.  Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.. Fluids Barriers CNS. 19(1):21.
Butler T, Chiang GC, Niogi SNarayan, Wang XHugh, Skudin C, Tanzi E, Wickramasuriya N, Spiegel J, Maloney T, Pahlajani S et al..  2022.  Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both? Front Neuroimaging. 1
2021
Mehta NH, Sherbansky J, Kamer AR, Carare RO, Butler T, Rusinek H, Chiang GC, Li Y, Strauss S, Saint-Louis LA et al..  2021.  The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans.. Front Physiol. 12:769948.
2020
Chen J, Hagiwara M, Givi B, Schmidt B, Liu C, Chen Q, Logan J, Mikheev A, Rusinek H, Kim SGene.  2020.  Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous F-FDG-PET and MRI.. Sci Rep. 10(1):20764.
2019
Glodzik L, Rusinek H, Tsui W, Pirraglia E, Kim H-J, Deshpande A, Li Y, Storey P, Randall C, Chen J et al..  2019.  Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension.. Hypertension. 73(1):197-205.
Butler T, Deshpande A, Harvey P, Li Y, Rusinek H, Pirraglia E, Osorio RS, Glodzik L, de Leon MJ, Madelin G et al..  2019.  Precisely-Measured Hydration Status Correlates with Hippocampal Volume in Healthy Older Adults.. Am J Geriatr Psychiatry. 27(6):653-654.
2018
Wake N, Chandarana H, Rusinek H, Fujimoto K, Moy L, Sodickson DK, Kim SGene.  2018.  Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration? Magn Reson Imaging. 52:16-23.
Butler T, Harvey P, Deshpande A, Tanzi E, Li Y, Tsui W, Silver C, Fischer E, Wang X, Chen J et al..  2018.  Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.. Neurobiol Aging. 65:201-205.
de Leon MJ, Pirraglia E, Osorio RS, Glodzik L, Saint-Louis L, Kim H-J, Fortea J, Fossati S, Laska E, Siegel C et al..  2018.  The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.. PLoS One. 13(2):e0191240.
Chen J, Li Y, Pirraglia E, Okamura N, Rusinek H, de Leon MJ.  2018.  Quantitative evaluation of tau PET tracers F-THK5351 and F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization.. Eur J Nucl Med Mol Imaging. 45(9):1596-1604.
de Leon MJ, Li Y, Rusinek H.  2018.  Reply: Cerebrospinal Fluid, Hyposmia, and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis.. J Nucl Med. 59(4):718-719.
2017
de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, Osorio RS, Fortea J, Butler T, Pirraglia E et al..  2017.  Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.. J Nucl Med. 58(9):1471-1476.
2016
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al..  2016.  Clearance systems in the brain--implications for Alzheimer diseaser.. Nat Rev Neurol. 12(4):248.
Glodzik L, Rusinek H, Kamer A, Pirraglia E, Tsui W, Mosconi L, Li Y, McHugh P, Murray J, Williams S et al..  2016.  Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.. Alzheimers Dement (Amst). 2:95-104.
2015
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al..  2015.  Clearance systems in the brain-implications for Alzheimer disease.. Nat Rev Neurol. 11(8):457-70.
Li Y, Tsui W, Rusinek H, Butler T, Mosconi L, Pirraglia E, Mozley D, Vallabhajosula S, Harada R, Furumoto S et al..  2015.  Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.. J Nucl Med. 56(2):270-3.
Glodzik L, Sollberger M, Gass A, Gokhale A, Rusinek H, Babb JS, Hirsch JG, Amann M, Monsch AU, Gonen O.  2015.  Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.. J Alzheimers Dis. 43(3):939-47.
Kamer AR, Pirraglia E, Tsui W, Rusinek H, Vallabhajosula S, Mosconi L, Yi L, McHugh P, Craig RG, Svetcov S et al..  2015.  Periodontal disease associates with higher brain amyloid load in normal elderly.. Neurobiol Aging. 36(2):627-33.
Glodzik L, Rusinek H, Li J, Zhou C, Tsui W, Mosconi L, Li Y, Osorio R, Williams S, Randall C et al..  2015.  Reduced retention of Pittsburgh compound B in white matter lesions.. Eur J Nucl Med Mol Imaging. 42(1):97-102.
2014
Glodzik L, Rusinek H, Pirraglia E, McHugh P, Tsui W, Williams S, Cummings M, Li Y, Rich K, Randall C et al..  2014.  Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.. Neurobiol Aging. 35(1):64-71.
Butler T, Zaborszky L, Pirraglia E, Li J, Wang XHugh, Li Y, Tsui W, Talos D, Devinsky O, Kuchna I et al..  2014.  Comparison of human septal nuclei MRI measurements using automated segmentation and a new manual protocol based on histology.. Neuroimage. 97:245-51.
2013
Glodzik L, Randall C, Rusinek H, de Leon MJ.  2013.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.. J Alzheimers Dis. 35(3):427-40.
Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S.  2013.  Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement.. J Magn Reson Imaging. 38(2):474-81.